1. Home
  2. TIL vs BNTC Comparison

TIL vs BNTC Comparison

Compare TIL & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$5.58

Market Cap

52.2M

Sector

Health Care

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$8.02

Market Cap

315.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TIL
BNTC
Founded
2018
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.2M
315.4M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TIL
BNTC
Price
$5.58
$8.02
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $23.75
AVG Volume (30 Days)
69.1K
★ 155.3K
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.14
$7.89
52 Week High
$13.50
$14.39

Technical Indicators

Market Signals
Indicator
TIL
BNTC
Relative Strength Index (RSI) 35.96 39.15
Support Level $5.56 N/A
Resistance Level $7.67 $13.87
Average True Range (ATR) 0.47 0.67
MACD -0.10 -0.06
Stochastic Oscillator 23.17 2.42

Price Performance

Historical Comparison
TIL
BNTC

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: